Home / Pharmaceuticals / Biosimulation Market By Software Type (PK/PD Modeling And Simulation, Molecular Modeling And Simulation, PBPK Modeling And Simulation, Toxicity Prediction, Trial Design), By Application (Drug Development, Drug Discovery) - Growth, Future Prospects, Competitive Analysis And Forecast 2017 - 2025

Biosimulation Market By Software Type (PK/PD Modeling And Simulation, Molecular Modeling And Simulation, PBPK Modeling And Simulation, Toxicity Prediction, Trial Design), By Application (Drug Development, Drug Discovery) - Growth, Future Prospects, Competitive Analysis And Forecast 2017 - 2025

Published: Nov 2017 | Report Code: 58787-11-17

The report titled “Global Biosimulation Market: Growth, Future Prospects, and Competitive Analysis, 2017 -2025” offers strategic insights into the overall biosimulation market along with the market size and estimates for the duration of 2015 to 2025. The said research study covers in-depth analysis of biosimulation market segments based on software type, application and different geographies further segmented by countries. Biosimulation techniques are the newest additions to the drug development industry which is based on simulation of biologic process via computer programs. This technique is widely used to predict the path of drug development and has proven beneficial in reducing patient numbers, time and cost incurred in the entire drug development process, thus proving beneficial for the pharmaceutical industries for its overall growth. Owing to the aforementioned benefits and an increase in awareness, demand and adoption of biosimulation, this market is presumed to have an increased growth in the forecasted period of 2017-2025.

For the purpose of this study, the global biosimulation market is segmented as follows:

  • By Software Type
    • PK/PD Modeling and Simulation Software
    • Molecular Modeling and Simulation Software
    • PBPK Modeling and Simulation Software
    • Toxicity Prediction Software
    • Trial Design Software
    • Other Software’s
  • By Application
    • Drug development
      • Preclinical testing
      • Clinical trials
    • Drug discovery
      • Lead Analysis (Identification & Optimization)
      • Target Analysis (Identification & Optimization)
    • Others

Market size estimates and forecast for these segments for the period 2015 to 2025 are provided in terms of US$ Mn along with the respective compounded annual growth rates (CAGRs) for the period 2017 to 2025, considering 2016 as the base year.

The geographical segmentation of the global biosimulation market comprised regions such as North America, Europe, Asia-Pacific, Latin America & Middle East and Africa. Each geographical region is further split to provide market revenue for select countries such as the U.S., Canada, U.K. Germany, China, Japan, Brazil, Mexico, Saudi Arabia, South Africa, and other countries. Market size and forecast for these segments during 2015 to 2025 and their CAGRs for the period 2017 to 2025 are provided in this report.

The biosimulation market is observed as the most diversified and competitive market comprising large number of players.  The market is dominated by several players, depending on their major competencies. The key players in this market are Certara USA, Inc., Simulation Plus, Inc., Dassault Systems SA, Schrodinger, Inc., Advanced Chemistry Development, Inc., Chemical Computing Group, Inc., Physiomics PLC, Entelos, Inc., Rhenovia Pharma Ltd., Genedata AG, Evidera, Inc., In Silico Biosciences Inc., Oxford Drug Design, Insilico Biotechnology AG, Leadinvent technologies Pvt Ltd. & Leadscope, Inc.

Biosimulation Market

Chapter 1. Preface
1.1. Report Scope and Description
1.2. Research Methodology
1.2.1. Phase I-Secondary Research
1.2.2. Phase II-Primary Research
1.2.3. Phase III-Expert Panel Review
1.2.4. Assumptions
1.2.5. Approach Adopted

Chapter 2. Executive Summary
2.1. Global Biosimulation Market Portraiture
2.1.1. Global Biosimulation Market, By Software Type, 2016 (US$ Mn)
2.1.2. Global Biosimulation Market, By Application , 2016 (US$ Mn)
2.1.3. Global Biosimulation Market, By Geography, 2016 (Value %)

Chapter 3. Biosimulation Market: Market Dynamics and Future Outlook
3.1. Market Overview
3.2. Biosimulation : Future Trends
3.3. Drivers
3.4. Challenges
3.5. Opportunities
3.6. Attractive Investment Proposition, by Geography, 2016
3.7. Major Agreements, Partnerships and Collaborations
3.8. Competitive Landscape, by Key Players, 2016

Chapter 4. Biosimulation Market, by Software Type, 2015 – 2025 (US$ Mn)
4.1. Overview
4.1.1. Attractive Investment Proposition: Global Biosimulation Market, by Software Type, 2016
4.2. PK/PD Modeling and Simulation Software
4.3. Molecular Modeling and Simulation Software
4.4. PBPK Modeling and Simulation Software
4.5. Toxicity Prediction Software
4.6. Trial Design Software
4.7. Other Software’s.

Chapter 5. Biosimulation Market, by Application , 2015 – 2025 (US$ Mn)
5.1. Overview
5.1.1. Attractive Investment Proposition: Global Biosimulation Market, by Application, 2016
5.2. Drug Development
5.2.1. Preclinical testing
5.2.2. Clinical trials
5.3. Drug Discovery
5.3.1. Lead Analysis (Identification & Optimization)
5.3.2. Target Analysis (Identification & Optimization)

Chapter 6. Global Biosimulation Market, by Geography, 2015 – 2025 (US$ Mn)
6.1. Overview
6.2. North America Biosimulation Market Analysis, 2015 – 2025
6.2.1. North America Biosimulation Market, By Software Type, 2015 – 2025 (US$ Mn)
6.2.2. North America Biosimulation Market, By Application , 2015 – 2025 (US$ Mn)
6.2.3. North America Biosimulation Market, by Country, 2015 – 2025 (US$ Mn)
6.2.3.1. U.S.
6.2.3.2. Canada
6.3. Europe Biosimulation Market Analysis, 2015 – 2025
6.3.1. Europe Biosimulation Market, By Software Type, 2015 – 2025 (US$ Mn)
6.3.2. Europe Biosimulation Market, By Application , 2015 – 2025 (US$ Mn)
6.3.3. Europe Biosimulation Market, by Country, 2015 – 2025 (US$ Mn)
6.3.3.1. U.K.
6.3.3.2. Germany
6.3.3.3. Rest of Europe
6.4. Asia Pacific Biosimulation Market Analysis, 2015 – 2025
6.4.1. Asia Pacific Biosimulation Market, By Software Type, 2015 – 2025 (US$ Mn)
6.4.2. Asia Pacific Biosimulation Market, By Application , 2015 – 2025 (US$ Mn)
6.4.3. Asia Pacific Biosimulation Market, by Country, 2015 – 2025 (US$ Mn)
6.4.3.1. Japan
6.4.3.2. China
6.4.3.3. Rest of APAC
6.5. Latin America Biosimulation Market Analysis, 2015 – 2025
6.5.1. Latin America Biosimulation Market, By Software Type, 2015 – 2025 (US$ Mn)
6.5.2. Latin America Biosimulation Market, By Application , 2015 – 2025 (US$ Mn)
6.5.3. Latin America Biosimulation Market, By Country, 2015 – 2025 (US$ Mn)
6.5.3.1. Mexico
6.5.3.2. Brazil
6.5.3.3. Rest of Latin America
6.6. Middle East & Africa (MEA) Biosimulation Market Analysis, 2015 – 2025
6.6.1. MEA Biosimulation Market, By Software Type, 2015 – 2025 (US$ Mn)
6.6.2. MEA Biosimulation Market, By Application , 2015 – 2025 (US$ Mn)
6.6.3. MEA Biosimulation Market, By Country, 2015 – 2025 (US$ Mn)
6.6.3.1. GCC
6.6.3.2. Rest of MEA

Chapter 7. Company Profiles
7.1. Medtronic
7.1.1. Business Description
7.1.2. Financial Information (Subject to data availability)
7.1.3. Product Portfolio
7.1.4. Key Developments
7.2. Certara USA, Inc.
7.3. Simulation Plus, Inc.
7.4. Dassault Systems SA
7.5. Schrodinger, Inc.
7.6. Advanced Chemistry Development, Inc.
7.7. Chemical Computing Group, Inc.
7.8. Physiomics PLC
7.9. Entelos, Inc.
7.10. Rhenovia Pharma Ltd.
7.11. Genedata AG
7.12. Evidera, Inc.
7.13. In Silico Biosciences Inc.
7.14. Oxford Drug Design
7.15. Insilico Biotechnology AG
7.16. Leadinvent technologies Pvt Ltd.
7.17. Leadscope, Inc.

List of Tables :

TABLE 1 Global Biosimulation Market, By Software Type, 2015 – 2025 (US$ Mn)
TABLE 2 Global Biosimulation Market Share, By Application , 2016 (US$ Mn)
TABLE 3 Global Biosimulation Market, By Drug Development, 2015 – 2025 (US$ Mn)
TABLE 4 Global Biosimulation Market, By Drug Discovery, 2015 – 2025 (US$ Mn)
TABLE 5 Global Biosimulation Market, By Geography, 2015 – 2025 (US$ Mn)
TABLE 6 North America Biosimulation Market, By Software Type, 2015 – 2025 (US$ Mn)
TABLE 7 North America Biosimulation Market, By Application, 2015 – 2025 (US$ Mn)
TABLE 8 North America Biosimulation Market, By Drug Development, 2015 – 2025 (US$ Mn)
TABLE 9 North America Biosimulation Market, By Drug Discovery, 2015 – 2025 (US$ Mn)
TABLE 10 North America Biosimulation Market, By Country, 2015 – 2025 (US$ Mn)
TABLE 11 Europe Biosimulation Market, By Software Type, 2015 – 2025 (US$ Mn)
TABLE 12 Europe Biosimulation Market, By Application , 2015 – 2025 (US$ Mn)
TABLE 13 Europe Biosimulation Market, By Drug Development, 2015 – 2025 (US$ Mn)
TABLE 14 Europe Biosimulation Market, By Drug Discovery, 2015 – 2025 (US$ Mn)
TABLE 15 Europe Biosimulation Market, By Country, 2015 – 2025 (US$ Mn)
TABLE 16 Asia Pacific Biosimulation Market, By Software Type, 2015 – 2025 (US$ Mn)
TABLE 17 Asia Pacific Biosimulation Market, By Application , 2015 – 2025 (US$ Mn)
TABLE 18 Asia Pacific Biosimulation Market, By Drug Development, 2015 – 2025 (US$ Mn)
TABLE 19 Asia Pacific Biosimulation Market, By Drug Discovery, 2015 – 2025 (US$ Mn)
TABLE 20 Asia Pacific Biosimulation Market, By Country, 2015 – 2025 (US$ Mn)
TABLE 21 Latin America Biosimulation Market, By Software Type, 2015 – 2025 (US$ Mn)
TABLE 22 Latin America Biosimulation Market, By Application , 2015 – 2025 (US$ Mn)
TABLE 23 Latin America Biosimulation Market, By Drug Development, 2015 – 2025 (US$ Mn)
TABLE 24 Latin America Biosimulation Market, By Drug Discovery, 2015 – 2025 (US$ Mn)
TABLE 25 Latin America Biosimulation Market, By Country, 2015 – 2025 (US$ Mn)
TABLE 26 Middle East And Africa Biosimulation Market, By Software Type, 2015 – 2025 (US$ Mn)
TABLE 27 Middle East And Africa Biosimulation Market, By Application , 2015 – 2025 (US$ Mn)
TABLE 28 Middle East And Africa Biosimulation Market, By Drug Development, 2015 – 2025 (US$ Mn)
TABLE 29 Middle East And Africa Biosimulation Market By Drug Discovery, 2015 – 2025 (US$ Mn)
TABLE 30 Middle East And Africa Biosimulation Market, by Country, 2015 – 2025 (US$ Mn)
TABLE 31 Certara USA, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 32 Simulation Plus, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 33 Dassault Systems SA: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 34 Schrodinger, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 35 Advanced Chemistry Development, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 36 Chemical Computing Group, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 37 Physiomics PLC: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 38 Entelos, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 39 Rhenovia Pharma Ltd.: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 40 Genedata AG: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 41 Evidera, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 42 In Silico Biosciences Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 43 Oxford Drug Design: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 44 Insilico Biotechnology AG: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 45 Leadinvent technologies Pvt Ltd.: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 46 Leadscope, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)

List of Figures :

FIG. 1 Biosimulation : Market Segmentation
FIG. 2 Attractive Investment Proposition, by Geography, 2016
FIG. 3 Market Competition Landscape, by Key Players, 2016
FIG. 4 Global PK/PD Modeling and Simulation Software Market In Biosimulation , 2015 – 2025 (US$ Mn)
FIG. 5 Global Molecular Modeling and Simulation Software Market In Biosimulation , 2015 – 2025 (US$ Mn)
FIG. 6 Global PBPK Modeling and Simulation Software Market In Biosimulation , 2015 – 2025 (US$ Mn)
FIG. 7 Global Toxicity Prediction Software Market In Biosimulation , 2015 – 2025 (US$ Mn)
FIG. 8 Global Trial Design Software Market In Biosimulation , 2015 – 2025 (US$ Mn)
FIG. 9 Global Other Software’s Market In Biosimulation , 2015 – 2025 (US$ Mn)
FIG. 10 Global Pre-clinical Market In Biosimulation , 2015 – 2025 (US$ Mn)
FIG. 11 Global Clinical Market In Biosimulation , 2015 – 2025 (US$ Mn)
FIG. 12 Global Lead Analysis Market In Biosimulation , 2015 – 2025 (US$ Mn)
FIG. 13 Global Target Analysis Market In Biosimulation , 2015 – 2025 (US$ Mn)
FIG. 14 U.S. Biosimulation Market, 2015 – 2025 (US$ Mn)
FIG. 15 Canada Biosimulation Market, 2015 – 2025 (US$ Mn)
FIG. 16 U.K. Biosimulation Market, 2015 – 2025 (US$ Mn)
FIG. 17 Germany Biosimulation Market, 2015 – 2025 (US$ Mn)
FIG. 18 Rest Of Europe Biosimulation Market, 2015 – 2025 (US$ Mn)
FIG. 19 Japan Biosimulation Market, 2015 – 2025 (US$ Mn)
FIG. 20 China Biosimulation Market, 2015 – 2025 (US$ Mn)
FIG. 21 Rest Of Asia Pacific Biosimulation Market, 2015 – 2025 (US$ Mn)
FIG. 22 Mexico Biosimulation Market 2015-2025 (US$ Mn)
FIG. 23 Brazil Biosimulation Market 2015-2025 (US$ Mn)
FIG. 24 Rest of Latin America Biosimulation Market 2015-2025 (US$ Mn)
FIG. 25 GCC Biosimulation Market 2015-2025 (US$ Mn)
FIG. 26 Rest of MEA Biosimulation Market 2015-2025 (US$ Mn)

Based on the type of software, the global biosimulation market is segmented as follows:

  • PK/PD Modeling and Simulation
  • Molecular Modeling and Simulation
  • PBPK Modeling and Simulation
  • Toxicity Prediction
  • Trial Design
  • Others.

Within this segment showcases a highly consolidated market share, as each and every software would be used during the course of drug development. Each modeling and simulation software are essential in predicting each step of drug development. These software’s would determine the course of a clinical trial and assess its success rate. Comparatively the PK/PD modeling and simulation software, molecular modeling and simulation software have a marginally higher market share owing to its majorly used applications such as dosage designing before a clinical trial, pharmacokinetic profiling of a drug or the success rate of drug administration on treatment outcome.

Biosimulation Market

Based on the application, the global biosimulation market is segmented as follows:

  • Drug development
    • Preclinical testing
    • Clinical trials
  • Drug discovery
    • Lead Analysis (Identification & Optimization)
    • Target Analysis (Identification & Optimization)
  • Others

The drug development segment encapsulates a larger share in the biosimulation market. This dominance is attributed due to increase in need for reduction in adverse effects associated with the current drugs available for treatment, which is propelling the demand for in silico systems to aid in development of improved molecules. The increased demand is also due to significant increase in success rates of computer based modeling in drug development. The drug discovery segment is also expected to grow in the forecast period of 2017-2025 owing to growing awareness of benefits of biosimulation such as bridging the gaps that hinder the drug discovery process which would enable lowering the drug failure rates. The demand for biosimulation in drug discovery would also rise in the forecast period as there would be an increased demand for personalized medicines which would require lead/target identification and optimization.

Biosimulation Market

For the purpose of this study, the biosimulation market is categorized into:

  • North America
  • Europe
  • Asia Pacific
  • Latin America (LATAM)
  • Middle East and Africa (MEA)

Biosimulation Market

Biosimulation provides simulation of biological system thus rendering most beneficial in the clinical trial development thus preventing the risks of drug failures. For the purpose of this study, the global biosimulation market is segmented into regional markets viz., North America, Europe, Asia Pacific, Latin America, Middle East and Africa. Of the aforementioned regions, North America encapsulated the largest share in the biosimulation market. The major factors that drive this predominance in the North American market are increase in drug development initiations, stringent regulatory policies ensuring patient safety and efficacy standards thus raising the demand to pre-analyze the success rate of the molecule before entering clinical trials, rise in number of strategic collaborations between pharmaceutical industries/research institute and in silico developers for simulation based drug development. Asia-Pacific is projected to show a positive growth biosimulation market during the forecast period, 2017-2025. The drivers propelling this market are increasing presence of CRO’s, development of healthcare infrastructure, penetration of healthcare IT and an extensive initiation of research and development activities.

Choose License Type
Connect With Us
+1-800-361-8290
24/7 Research Support

Credence Webinars

Join Credence analysts to explore the latest IT Trends

view upcoming webinars

Our Clients